MannKind Corporation
Method of treating diabetes type 2 by administering ultrarapid acting insulin
Last updated:
Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Status:
Grant
Type:
Utility
Filling date:
2 Mar 2018
Issue date:
8 Dec 2020